Transcriptomic analyses following RP-6306 treatment in pancreatic cancer cells have revealed a significant upregulation of genes implicated in several inflammation-associated pathways, including MAPK, PI3K/Akt, JAK/Stat, and NF-κB. The gene discussed is AKT1; the disease is familial pancreatic carcinoma.